GLTO
Price
$3.07
Change
+$0.22 (+7.72%)
Updated
Apr 25, 01:42 PM (EDT)
Capitalization
3.77M
LSB
Price
$1.28
Change
-$0.05 (-3.76%)
Updated
Apr 25, 02:00 PM (EDT)
Capitalization
25.38M
Ad is loading...

GLTO vs LSB

Header iconGLTO vs LSB Comparison
Open Charts GLTO vs LSBBanner chart's image
Galecto
Price$3.07
Change+$0.22 (+7.72%)
Volume$100
Capitalization3.77M
LakeShore Biopharma
Price$1.28
Change-$0.05 (-3.76%)
Volume$100
Capitalization25.38M
GLTO vs LSB Comparison Chart
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. LSB commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Buy and LSB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GLTO: $2.85 vs. LSB: $1.33)
Brand notoriety: GLTO and LSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 4% vs. LSB: 199%
Market capitalization -- GLTO: $3.77M vs. LSB: $25.38M
GLTO [@Biotechnology] is valued at $3.77M. LSB’s [@Biotechnology] market capitalization is $25.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileLSB’s FA Score has 1 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • LSB’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLTO and LSB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 3 TA indicator(s) are bullish while LSB’s TA Score has 3 bullish TA indicator(s).

  • GLTO’s TA Score: 3 bullish, 6 bearish.
  • LSB’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both GLTO and LSB are a bad buy in the short-term.

Price Growth

GLTO (@Biotechnology) experienced а +17.28% price change this week, while LSB (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.19%. For the same industry, the average monthly price growth was -4.22%, and the average quarterly price growth was -12.54%.

Reported Earning Dates

GLTO is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+7.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSB($25.4M) has a higher market cap than GLTO($3.77M). GLTO YTD gains are higher at: -38.710 vs. LSB (-61.561). GLTO has higher annual earnings (EBITDA): -19.68M vs. LSB (-220.1M). LSB has more cash in the bank: 49.5M vs. GLTO (19.7M). GLTO has less debt than LSB: GLTO (32K) vs LSB (369M). LSB has higher revenues than GLTO: LSB (672M) vs GLTO (0).
GLTOLSBGLTO / LSB
Capitalization3.77M25.4M15%
EBITDA-19.68M-220.1M9%
Gain YTD-38.710-61.56163%
P/E RatioN/AN/A-
Revenue0672M-
Total Cash19.7M49.5M40%
Total Debt32K369M0%
TECHNICAL ANALYSIS
Technical Analysis
GLTOLSB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 22 days ago
88%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
41%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPEAX5.56N/A
N/A
Voya Large Cap Value Port A
FRSLX22.55N/A
N/A
Nuveen Small/Mid Cap Growth Opp A
JGMRX20.66N/A
N/A
Janus Henderson Triton R
GGUPX8.52N/A
N/A
Goldman Sachs Global Rl Estt Secs P
DWOIX17.15N/A
N/A
BNY Mellon Research Growth I

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with XERS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+3.64%
XERS - GLTO
41%
Loosely correlated
+3.63%
SYRE - GLTO
39%
Loosely correlated
+4.99%
ACLX - GLTO
35%
Loosely correlated
+0.53%
RGNX - GLTO
35%
Loosely correlated
+3.72%
RCKT - GLTO
35%
Loosely correlated
+4.06%
More

LSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSB has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSB jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
N/A
STTK - LSB
38%
Loosely correlated
-1.57%
GLTO - LSB
32%
Poorly correlated
+3.64%
BCTX - LSB
30%
Poorly correlated
+11.05%
GNFT - LSB
23%
Poorly correlated
+0.78%
IMRX - LSB
22%
Poorly correlated
+3.55%
More